Announcements

  • Home
  • Announcements

Announcements

At Stendhal we are committed to complying with the highest standards of business integrity and applicable local and international legislation, considered relevant in terms of anti-corruption, transparency, money laundering prevention, economic competition, as well as industry codes. , so below you can find the most recent releases.


Boletin Epilepsia

26 Enero 2023

Boletin Migraña

26 Enero 2023

Comunicado Alianza Stendhal Nutricia

26 Enero 2023

Comunicado Semana de la Innovacion Stendhal

26 Enero 2023

Comunicado Stendhal Alnylam

26 Enero 2023

Comunicado Stendhal Biomarin

26 Enero 2023

Detecta los primeros sintomas silenciosos que Causa la Hipertension Arterial

26 Enero 2023

Media Alert Blue Monday

26 Enero 2023

Rodrigo Ruiz Reelegido Presidente de AMIIF

26 Enero 2023

Stendhal Alianza Estrategica con Adienne

26 Enero 2023

Stendhal es reconocida como empresa de diez por el Infonavit

26 Enero 2023

Stendhal reconocida empresa ética

26 Enero 2023

Stendhal tratamiento para la reducción y control de riesgo cardiovascular

26 Enero 2023

Valdoxa

26 Enero 2023

Business Development

In Stendhal we generate shared value, we develop long-term alliances strengthening our portfolio to meet the health needs of the region.

Join the Team

We are open to professionals with a high level of initiative, with the capacity to transform uncertainty into opportunities.


Logotipo

© Stendhal International 2022 All Rights Reserved
Stendhal Pharma is property of Específicos Stendhal, S.A. de C.V.

Follow us: